683 Capital Management’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.52M | Sell |
42,000
-8,000
| -16% | -$670K | 0.23% | 74 |
|
|
2025
Q1 | $3.57M | Hold |
50,000
| – | – | 0.25% | 72 |
|
|
2024
Q4 | $2.25M | Sell |
50,000
-1,322
| -3% | -$59.4K | 0.14% | 76 |
|
|
2024
Q3 | $2.59M | Sell |
51,322
-18,678
| -27% | -$943K | 0.2% | 74 |
|
|
2024
Q2 | $2.86M | Sell |
70,000
-8,000
| -10% | -$326K | 0.22% | 65 |
|
|
2024
Q1 | $3.34M | Sell |
78,000
-9,000
| -10% | -$385K | 0.24% | 57 |
|
|
2023
Q4 | $3.5M | Hold |
87,000
| – | – | 0.29% | 56 |
|
|
2023
Q3 | $2.57M | Buy |
+87,000
| New | +$2.57M | 0.2% | 63 |
|
|
2020
Q2 | – | Sell |
-26,667
| Closed | -$952K | – | 148 |
|
|
2020
Q1 | $952K | Sell |
26,667
-1,459
| -5% | -$52.1K | 0.11% | 76 |
|
|
2019
Q4 | $1.24M | Sell |
28,126
-9,813
| -26% | -$433K | 0.14% | 58 |
|
|
2019
Q3 | $854K | Hold |
37,939
| – | – | 0.1% | 69 |
|
|
2019
Q2 | $1.59M | Hold |
37,939
| – | – | 0.14% | 69 |
|
|
2019
Q1 | $1.17M | Sell |
37,939
-18,335
| -33% | -$566K | 0.11% | 72 |
|
|
2018
Q4 | $1.44M | Hold |
56,274
| – | – | 0.09% | 70 |
|
|
2018
Q3 | $1.82M | Hold |
56,274
| – | – | 0.12% | 57 |
|
|
2018
Q2 | $1.98M | Hold |
56,274
| – | – | 0.13% | 66 |
|
|
2018
Q1 | $1.53M | Hold |
56,274
| – | – | 0.14% | 66 |
|
|
2017
Q4 | $1.52M | Buy |
56,274
+54,274
| +2,714% | +$1.47M | 0.13% | 70 |
|
|
2017
Q3 | $78K | Buy |
+2,000
| New | +$78K | 0.01% | 93 |
|